Dietary Intervention Prevents Dyslipidemia Associated with Highly Active Antiretroviral Therapy in HIV-1- infected Individuals: A Randomized Trial Rosmeri.

Slides:



Advertisements
Similar presentations
CHER Trial: Early Antiretroviral Therapy and Mortality Among HIV- Infected Infants New England J Med 2008;359 (21):
Advertisements

10 Points to Remember for the Management of Overweight and Obesity in Adults Management of Overweight and Obesity in Adults Summary Prepared by Elizabeth.
Plant stanol ester in the treatment and prevention guidelines 0.
10 Points to Remember on Lifestyle Management to Reduce Cardiovascular RiskLifestyle Management to Reduce Cardiovascular Risk Summary Prepared by Elizabeth.
OBESITY and CHD Nathan Wong. OBESITY AHA and NIH have recognized obesity as a major modifiable risk factor for CHD Obesity is a risk factor for development.
TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.
Introductions Name address Favorite type of food Least favorite food Magazine you read most often All-time favorite movie Concert/performance you’d.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Diabetes Trials Unit University of Oxford WebSite: Lipids in Diabetes Study.
The Science of Plant Stanol Ester. Contents Background Plant stanol ester and LDL-cholesterol lowering Dose-response of plant stanol ester with high daily.
Reading Food Labels.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
CE-1 CRESTOR ® Clinical Development Efficacy James W. Blasetto, MD, MPH Senior Director, Clinical Research.
Role of Rosuvastatin in the Treatment of Dyslipidemia
Note Final Exam-please check final schedule Essays due-lateness unacceptable.
Hyperlipidemia John Baer.
Appendix: Clinical Guidelines VBWG. I Intervention is useful and effective III Intervention is not useful or effective and may be harmful A Data derived.
M ALNUTRITION. M ALNUTRITION AMONG IDU S : B ASIC FACTS Drug users are at increased risk of malnutrition regardless of whether or not they are infected.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Medical Management of obesity Perinatal ANGELS Conference Feb 17, 2005 Philip A. Kern.
© 2003 By Default! A Free sample background from Slide 1 Information Technology- Based Mechanism for the Management of Obesity.
Nonvitamin, Nonmineral Dietary Supplementation in HIV-Positive People Nutrition in Clinical Practice 22: , December 2007 American Society for Parenteral.
Metabolic Syndrome Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD.
Leptin Replacement Therapy Improves Insulin Resistance in Highly Active Antiretroviral Therapy (HAART) Induced Lipodystrophy and Metabolic Syndrome in.
Taipei Medical University. Adolescents with Higher Althernate Healthy Eating Index For Taiwan (AHEI-T) Scores Have Lower Blood Lipid Level De-Zhi Weng,
EFFECTIVENESS OF A MEDICAL EDUCATION INTERVENTION TO TREAT HYPERTENSION IN PRIMARY CARE Authors Institutions Authors: Silvia Martínez-Valverde MSc 1, Hortensia.
© 2003, Wellsource Inc. Effect of Ketogenic Diet on Lipid Levels (shown is LDL-C) In this group of 141 children followed for 6 months, a ketogenic diet.
Metabolic Syndrome in HIV- Infected Patients from MTCT-Plus, Thai Outpatient Population J. JANTARAPAKDE1,2,*, C. CHATURAWIT1,2, S. PENGNONYANG1,2, W. PIMA1,
SATURN: Objective To compare the effects of rosuvastatin 40 mg versus atorvastatin 80 mg on progression of coronary atherosclerosis assessed by intravascular.
A randomized open study comparing the impact of reducing stavudine dose vs. switching to tenofovir on mitochondrial function, metabolic parameters, and.
VBWG BRAVER Trial BRachial Artery Vascular Endothelium Reactivity Study A substudy of PROVE IT-TIMI 22.
Hsia J et al. J Am Coll Cardiol 2011;57: Baseline Characteristics by Treatment Group and Attained LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:
Clinical Trial Results. org METEOR Trial Presented at the American College of Cardiology Annual Scientific Session March, 2007 Presented by Dr. John R.
Ezetimibe Overall Conclusions
CDA exercise guidelines 150 minutes moderate – intensity (60 – 70% of max) aerobic over minimum 3 non consecutive days PLUS resistance exercise 3.
Long-Term Changes in Lipids and Glucose/Insulin among HIV-Infected Antiretroviral Naïve Persons Randomized to PI vs. NNRTI vs. PI+NNRTI-based strategies:
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2013 ACC/AHA Guideline on the Treatment of Blood.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Flaxseed in Pediatric Hyperlipidemia Wong H, Chahal N, Manlhiot C, Niedra E, McCrindle.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
The effect of restricted diet with olive oil versus fish oil combined with endurance exercise on Dyslipidemic females Prof. Dr. Samy A. Nassif PhD, PT.
Data Sources Definitions
Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD
Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial Michael Miller MD,
Therapeutic Lifestyle
Note Final Exam-please check final schedule.
5. Example - the Coronary Drug Project (CDP)
From ESH 2016 | POS 7D: Jan Rosa, MD
Copyright © 2017 American Academy of Pediatrics.
Atazanavir + ritonavir vs. Lopinavir-ritonavir CASTLE Study
Saquinavir + RTV versus Lopinavir-RTV in Treatment-Naïve GEMINI Trial
Switching to TDF-FTC from ABC-3TC for Hyperlipidemia ROCKET II
National Cholesterol Education Program
Oxford Niacin Trial.
The Chemical Differences Between EPA and DHA.
Development of the Healthy Eating Index-2005
Note Final Exam-please check final schedule.
Note Final Exam-please check final schedule
Note Final Exam-please check final schedule.
Contemporary Evidence-Based Guidelines
Note Final Exam-please check final schedule.
Changes In Nutrient Intake And Dietary Quality Among Participants With Type 2 Diabetes Following A Low-fat Vegan Diet Or A Conventional Diabetes Diet For.
Serum Vitamin C (mg/dl) by Salad Intake
Goals & Guidelines A summary of international guidelines for CHD
--- 6-months’ therapy months’ therapy Supplementary Figure 1.
Section 6: Update on lipid treatment guidelines
Presentation transcript:

Dietary Intervention Prevents Dyslipidemia Associated with Highly Active Antiretroviral Therapy in HIV-1- infected Individuals: A Randomized Trial Rosmeri K. Lazzaretti, RD, MSc, Regina Kuhmmer, RD, MSc, Eduardo Sprinz, MD, ScD, Carísi A. Polanczyk, MD, ScD, Jorge P. Ribeiro, MD, ScD

Objective  To evaluate the efficacy of dietary intervention on blood lipids of HIV-infected patients who are started on highly active antiretroviral therapy (HAART). J Am Coll Cardiol 2012;59:979-88

Background  Current guidelines recommend diet as first step intervention for HIV-1-infected individuals with HAART-related dyslipidemia, but there is no evidence from randomized trials to support this recommendation. J Am Coll Cardiol 2012;59:979-88

Methods  Eighty-three HIV-1-infected patients, naïve from HAART, were randomly assigned to HAART with dietary intervention (Diet, n = 43) or HAART without dietary intervention (Controls, n = 40) for 12 months.  Diet, according to the National Cholesterol Education Program, was given every 3 months.  Before and after intervention, 24 hour food records and lipid profile were obtained.  Data were analyzed by intention to treat, using mixed-effects models. J Am Coll Cardiol 2012;59:979-88

Results  Diet resulted in reduction of percentage of fat intake (from 31±7 to 21±3% of calories), while Controls presented no change in percentage of fat intake.  Plasma cholesterol (151±29 to 190±33 mg/dl) and LDL-C (85±24 to 106 ±31 mg/dl) increased in the Controls but were unchanged in the Diet group.  Plasma triglycerides were reduced by Diet (from 135 ±67 to 101±42 mg/dl) and increased in Controls (from 134±70 to 160±76 mg/dl).  After 1-year follow-up, 21% of patients who received Diet had a lipid profile compatible with dyslipidemia compared to 68% (p < 0.001) of Controls. J Am Coll Cardiol 2012;59:979-88

Study Flow Diagram J Am Coll Cardiol 2012;59:979-88

Effects on Body Mass Index and Blood Lipids Effect of the nutritional intervention during 12 months on body mass index (Panel A), total cholesterol levels (Panel B), LDL-C (Panel C), and triglycerides (Panel D). Values are expressed as mean ± SD. J Am Coll Cardiol 2012;59:979-88

Conclusion  Among HIV-1-positive individuals naïve of previous treatment, Diet prevents dyslipidemia associated with HAART. J Am Coll Cardiol 2012;59:979-88

Clinical Trial Registration: Unique identifier: NCT